Work at Axsometherapeutics.

Axsome Therapeutics is a biopharmaceutical company focused on developing and commercializing treatments for central nervous system disorders. It is a publicly traded company based in New York with approved products and a pipeline targeting...

Healthcare Biopharma Biotechnology Therapeutics

Open roles 6

Founded 2012

Type Public · AXSM

Team size 501–1,000

Headquarters New York

Website axsome.com

Legal name Axsome Therapeutics Inc.

View on LinkedIn →

Open roles at Axsometherapeutics

6 open roles

Senior Manager, Data Management New York · New York Salary TBC 5 days ago

Associate Director, IT Business Solutions New York · New York $170,000–$190,000 26 days ago

Director, IT Operations New York · New York Salary TBC 28 days ago

Associate Director/Director, Information Security New York · New York $170,000–$220,000 / year 35 days ago

Associate Director/Director, Payer Marketing New York · New York $175,000–$225,000 / year 55 days ago

Associate Director, HEOR Analytics New York · New York $175,000–$195,000 82 days ago

About Axsometherapeutics

Products & services

Auvelity® (dextromethorphan and bupropion) An extended-release oral prescription medicine approved for major depressive disorder and agitation associated with dementia due to Alzheimer’s disease.
Sunosi® (solriamfetol) An oral prescription medicine used to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
Symbravo® (meloxicam and rizatriptan) A 20 mg/10 mg oral combination tablet for the acute treatment of migraine attacks, with or without aura, in adults.
AXS-05 An oral investigational combination of dextromethorphan and bupropion being developed for Alzheimer’s disease agitation and smoking cessation.
AXS-12 (reboxetine) An oral investigational selective norepinephrine reuptake inhibitor in Phase 3 development for narcolepsy, including potential effects on wakefulness and muscle tone.
AXS-14 (esreboxetine) An oral investigational selective norepinephrine reuptake inhibitor in development for the treatment of fibromyalgia.

Leadership

Herriot Tabuteau Chief Executive Officer

Seniority mix

Entry & junior 0 roles
Mid-level 0 roles
Senior 0 roles
Lead & principal 1 role
Manager & above 4 roles

Based on 5 open roles

Where they hire

New York, NY 5 roles

Based on 5 roles with a listed city

Brands & subsidiaries

SUNOSI

Work at Axsometherapeutics.

Open roles at Axsometherapeutics

Subscribe to Career Resources.

Your cookie choices